These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2644877

  • 1. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS.
    Angiology; 1989 Feb; 40(2):122-8. PubMed ID: 2644877
    [Abstract] [Full Text] [Related]

  • 2. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
    Corbin DO, Wood DA, Macintyre CC, Housley E.
    Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, Kirby JD.
    BMJ; 1989 Mar 04; 298(6673):561-4. PubMed ID: 2467711
    [Abstract] [Full Text] [Related]

  • 4. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
    Smith CD, McKendry RJ.
    Lancet; 1982 Dec 11; 2(8311):1299-301. PubMed ID: 6128596
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A, Martelli E, Bavera P, Agus GB.
    Int Angiol; 1987 Dec 11; 6(4):359-63. PubMed ID: 3330116
    [Abstract] [Full Text] [Related]

  • 11. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M.
    Rev Rhum Mal Osteoartic; 1982 Apr 11; 49(5):337-43. PubMed ID: 6285445
    [Abstract] [Full Text] [Related]

  • 12. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D.
    J Rheumatol; 1984 Jun 11; 11(3):362-4. PubMed ID: 6376801
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    Vasa Suppl; 1987 Jun 11; 18():68-70. PubMed ID: 3299818
    [No Abstract] [Full Text] [Related]

  • 15. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T, Hartling OJ, Kelbaek H, Nielsen SL.
    Eur J Clin Pharmacol; 1986 Jun 11; 31(4):387-9. PubMed ID: 3816916
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Jun 11; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 17. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
    Ettinger WH, Wise RA, Schaffhauser D, Wigley FM.
    Am J Med; 1984 Sep 11; 77(3):451-6. PubMed ID: 6540986
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.